LEONA ROSE: Open Payments
NPI 1275805202 · CHEROKEE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 68 payments from 11 companies in 2025. Trend: 2023 $962 · 2024 $1,268 · 2025 $1,397
Food & beverage: $1,286Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $410 |
| Teva Pharmaceuticals USA, Inc. | 15 | $357 |
| Neurocrine BioSciences, Inc. | 10 | $193 |
| Janssen Pharmaceuticals, Inc | 6 | $110 |
| Lundbeck LLC | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Alkermes, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $16 |
Products named: COBENFY, INGREZZA, UZEDY, ABILIFY MAINTENA, FANAPT, AUSTEDO XR, INVEGA SUSTENNA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
